Generation of rapid, strong and long-lasting antibody responses is crucial for development of effective vaccines against infectious diseases.
Vaccibody has over the last years studied the vaccine effect in different infectious disease models like Influenza, Herpes Simplex Virus 2 and Tuberculosis with academic and industrial partners.
The studies have shown that Vaccibody vaccines are able to protect against infectious diseases through generation of neutralizing antibodies and Helper T cell responses after a single administration with a needle-free jet injector.
The data have been generated with both DNA and Protein Vaccibody formulations demonstrating the broad potential of our Vaccine Technology Platform.
